Proposal to fund blood glucose and blood ketone testing products via a PSO
24 May 2013
PHARMAC is seeking feedback on a proposal to fund blood glucose and blood ketone testing products via a PSO from 1 July 2013.
In summary, this proposal would result in blood glucose and blood ketone testing products being available on a PSO with quantity restrictions.
PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by Monday, 10 June 2013 to:
Therapeutic Group Manager
PO Box 10 254
Fax: 04 460 4995
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA. Anyone providing feedback, whether on their own account or on behalf of an organisation, and whether in a personal or professional capacity, should be aware that the content of their feedback and their identity may need to be disclosed in response to an OIA request.
We are not able to treat any part of your feedback as confidential unless you specifically request that we do, and then only to the extent permissible under the OIA and other relevant laws and requirements. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like it withheld. PHARMAC will give due consideration to any such request.
Last updated: 3 March 2016